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Abstract
Avian scavengers, such as American crows (Corvus brachyrhynchos), have potential to translocate infectious agents (prions)
of transmissible spongiform encephalopathy (TSE) diseases including chronic wasting disease, scrapie, and bovine
spongiform encephalopathy. We inoculated mice with fecal extracts obtained from 20 American crows that were force-fed
material infected with RML-strain scrapie prions. These mice all evinced severe neurological dysfunction 196–231 d
postinoculation (x = 198; 95% CI: 210–216) and tested positive for prion disease. Our results suggest a large proportion of
crows that consume prion-positive tissue are capable of passing infectious prions in their feces (p̂ = 1.0; 95% CI: 0.8–1.0).
Therefore, this common, migratory North American scavenger could play a role in the geographic spread of TSE diseases.
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Introduction
Transmissible spongiform encephalopathies (TSE) are most
likely caused by pathogenic isoforms (PrPRes) of prion proteins [1]
that naturally occur across many classes of animals, including
mammals and birds [2]. A number of livestock and wildlife species
in North America are susceptible to TSE diseases. Mule deer
(Odocoileus hemionus), white-tailed deer (O. virginianus), elk (Cervus
elaphus), and moose (Alces alces) are susceptible to chronic wasting
disease (CWD); domestic sheep and goats are susceptible to
scrapie; and domestic cattle are susceptible to bovine spongiform
encephalopathy (BSE) (although this disease is rare in North
America [3]). These TSE diseases are always fatal to infected
animals, and upon death, carcasses allowed to remain in the
environment can be scavenged by an array of avian and
mammalian scavengers [4].
Mechanisms for the spread of TSE in wild and domestic
ungulates are incompletely understood. We hypothesized that
avian scavengers have potential to translocate PrPRes in their feces.
American crows (Corvus brachyrhynchos) are significant avian
scavengers of deer carcasses [4], they are migratory, and their
overall range [5] includes most areas where TSE diseases occur in
North America [6]. Crows forage in groups, traveling up to
80 km/d from communal roosts [5]. Thus, crows have opportu-
nity to encounter PrPRes-infected carcasses, consume infected
tissue, and move long distances before depositing feces. Once in
the soil, PrPRes may persist .2 years [7,8], potentially enabling
increased site contamination over time. For example, residual
contamination of soil with PrPRes caused recurrence of CWD in
confined mule deer in Colorado [7] and lateral transmission via
environmental contamination is likely an important route of
infection [9].
Insects [10,11], poultry [12], and scavengers, including crows
[4], have been suggested as passive carriers or dispersers of
infectious prions. We found no studies that evaluated passage of
PrPRes through avian digestive systems, though several studies
have evaluated resistance of PrPRes to mammalian digestive fluids.
Ruminant digestive fluids used during in-vitro trials have shown
substantial [13,14] to no reduction [15] in Western blot signal
after incubation periods of approximately 13–24 h. Shorter
incubation times (15–210 min) resulted in intermediate levels of
Western blot signal loss [16]. Studies that investigated effects on
PrPRes from full passage through rodent digestive systems found
scrapie and BSE PrPRes present in mouse feces [17] and scrapie
PrPRes in hamster feces (ca. 5% of original dose excreted 24 h
postinoculation) [18]. Thus, it appears that mammalian digestive
fluids and processes can reduce PrPRes concentration but are
unlikely to eliminate it.
Proteolysis occurs in the avian digestive system due to the
presence of hydrochloric acid (HCl) and the proteolytic enzymes
pepsin, trypsin, chymotrypsin and various peptidases [19,20].
Although experimentally induced hypoacidity was associated with
reduced scrapie infection rates in mice [21], it is unlikely that
gastric HCl would fully degrade PrPRes in the crow digestive
system given extreme temperature and concentration required
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[22] and mild conditions present in the avian gut [19,23].
Although early investigations suggested that trypsin reduced
scrapie titer under certain circumstances [1,24], subsequent studies
found pepsin and trypsin were not effective for reducing infectivity
of scrapie and BSE PrPRes [25] or variant Creutzfeldt-Jakob
disease PrPRes [26]. Thus, there is little evidence to suggest that the
crow digestive system would eliminate PrPRes infectivity prior to
excretion of feces. Similar arguments can be made for nonrumi-
nant mammals because of similarities in endogenous enzymes in
vertebrate digestive systems [27], yet PrPRes was substantially
reduced by passage through hamster digestive systems [18].
Little is known about effects of avian digestive systems on
infectivity of PrPRes. As a first step in understanding the potential
role of avian scavengers in TSE transmission, we tested the
hypothesis that readily available mouse-adapted scrapie PrPRes
can remain infectious after passage through the digestive tract of
crows. Results of our study support this hypothesis.
Materials and Methods
We evaluated infectivity of the RML Chandler strain (RML) of
mouse-adapted scrapie [28] (obtained from Rocky Mountain
Laboratories, Hamilton, MT) after passage through digestive
systems of crows. Crows were captured during winter in central
Oklahoma, USA. We used mouse-brain source material from
uninfected (normal) and terminally ill RML-infected C57BL/6
mice (Hilltop Lab Animals, Scottsdale, PA; this strain used
throughout study). We separately pooled and homogenized
infected and normal mouse brains and diluted portions of each
homogenate 1:10 w/v in sterile phosphate-buffered saline (SPBS).
We estimated passage time through the alimentary canal by
gavaging 1 crow (not part of the experimental group) with 5 ml of
whole egg mixed with blue dye; by 4 h postgavage all stained feces
had been excreted. We withdrew feed (but not water) from study
crows approximately 17 h pregavage. We randomly allocated 25
crows to treatment groups and gavaged each crow with 5 ml of
either PrPRes-infected (n = 20) or normal (n = 5) mouse-brain
homogenate diluted 1:10 w/v in SPBS (Table 1). We then
transferred each crow to an individual single-use cage. At 4 h
postgavage, we collected and pooled all feces within each cage. We
homogenized crow-specific pooled feces and gamma irradiated
them at 24,000 Gy to destroy viruses and microbes. For each
crow, we then diluted a 500 ml sample of fecal homogenate in
SPBS to a total volume of 10 ml, centrifuged it for 15 min at
13,730 m/s2, and extracted the supernatant for use as inoculum
for mice. We removed solids to minimize risk of toxicity to mice
from uric acid contained in bird feces. Crows were not held or
examined after collection of fecal samples.
We randomly allocated 5 mice/crow to treatment groups
(Table 1). Mice received crow-specific fecal supernatant from
PrPRes or control crows (CF+ and CF2 groups, respectively), or
PrPRes-infected or normal mouse brain homogenate diluted to
1:100 w/v in SPBS (MB+ and MB2 groups, respectively). We
intraperitoneally inoculated each mouse with 1 ml of either crow
fecal supernatant or diluted mouse brain homogenate.
All 5 mice/crow, or 5 mice/MB treatment group, were caged
together under biosafety level 2 conditions. We monitored mice
daily until all those in PrPRes treatment groups expressed clinical
symptoms of mouse scrapie and were thereafter euthanized.
Remaining mice were monitored every 2 d until study termination
at 365 d postinoculation (dpi). We scored mice for each of 6
clinical symptoms of mouse scrapie (kyphosis, ataxia, stiff tail, lack
of grooming, emaciation, and lethargy), where 0 = none visible,
1 = moderate, and 2 = severe. We euthanized mice when total
daily scores reached $8 for 1 d, $6 continuously for 3 d, or at
365 dpi. Brains were immediately harvested and stored at 270uC
for analysis. Samples from harvested brains (1:10 w/v homoge-
nate) were tested at Colorado State University’s Veterinary
Diagnostic Laboratory for PrPRes using the ELISA-based Bio-
Rad TeSeE BSE rapid assay (Bio-Rad Laboratories, Hercules,
CA, USA) to confirm scrapie diagnosis.
We used exact methods [29] to estimate a 95% confidence
interval (CI) on the proportion of crows able to excrete infectious
prions in feces (SAS PROC FREQ [30]). We used Fisher’s exact
test, due to low count (i.e., 2) in 1 cell of the 262 contingency
table, to evaluate whether early death (#3 dpi) was associated with
source of CF inoculum (PrPRes or control). We estimated means
and 95% CI for incubation time or time-to-death (contingent on
surviving .3 dpi) for CF+ and MB+ mice using general linear
mixed modeling [31], where cage was a random effect to account
for clustering of mice within cages (SAS PROC GLIMMIX [30]).
Traditional time-to-event (or survival) analyses were not required
for CF+ and MB+ mice because none were censored .3 dpi. As
most CF2 mice were censored at study termination, we tested for
equality of survival functions between CF+ and CF2 using the
log-rank test (SAS PROC LIFETEST [30]).
Ethics Statement
The Institutional Animal Care and Use Committee of the
United States Department of Agriculture, Animal and Plant
Health Inspection Service, Wildlife Services, National Wildlife
Research Center approved all procedures used in this study (QA-
1406).
Results
All 20 crows gavaged with scrapie-infected mouse brain
transmitted PrPRes to mice via fecal inoculum (estimated
proportion: p̂ = 1.00, CI: 0.83–1.00). Sixteen mice from CF+
and 2 from CF2 groups died #3 d postinoculation (likely from
residual uric acid toxicity; Table 2). No early deaths occurred in
MB groups and estimated probabilities of early death were not
statistically different between CF+ (p̂ = 0.16) and CF2 (p̂ = 0.08)
mice (Fisher’s exact P = 0.524). After these early deaths, 2 crows
were represented by only 1 mouse/crow and all other crows were
represented by 3–5 mice/crow. Surviving mice appeared healthy
until onset of clinical symptoms of mouse scrapie. Based on scoring
for multiple clinical symptoms, we euthanized mice in MB+ and
Table 1. Experimental design used to estimate proportion of
crows able to pass infectious RML scrapie prion (PrPRes) in
feces (numbers of animals).
Treatment groupA Crows MiceB
CF+ 20 100
CF2 5 25
MB+ 0 10
MB2 0 5
AMice intraperitoneally inoculated with gamma-irradiated crow fecal (CF)
extract from crows gavaged with PrPRes (+) or control (2) mouse brain
homogenate; additional control mice were inoculated with mouse-brain
homogenate with (MB+) or without (MB2) PrPRes.
BFive mice were randomly allocated to each crow and housed together in 1
cage postinoculation. Additional control mice were allocated randomly to MB
treatment groups and 5 mice/treatment group were housed together in 1 cage
postinoculation.
doi:10.1371/journal.pone.0045774.t001
Infectious Prion and Crow Digestive System
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CF+ groups 181–231 dpi (Fig. 1). These mice subsequently tested
positive for PrPRes (Table 2). On average, MB+ mice had shorter
incubation times (by 15 d) than CF+ mice (Fig. 1). We observed no
clinical symptoms in MB2 or CF2 control mice. All MB2 mice
lived to study termination at 365 dpi, though 3 CF2 mice died at
251–303 dpi. Time to death was significantly longer for CF2 than
for CF+ mice (x21 = 71.0, p,0.0001). One of these CF2 mice
(251 dpi) tested positive for PrPRes. This unexpectedly positive
mouse was inoculated directly after 5 MB+ mice and may have
been inadvertently exposed to PrPRes-positive material.
Discussion
We tested the hypothesis that PrPRes would remain infectious
after passage through the digestive tract of crows. After inoculation
with fecal supernatant from crows gavaged with PrPRes-infected
material, we observed clinical disease and obtained positive results
from ELISA in all 84 CF+ mice that survived .3 dpi. Thus, we
confirmed passage of infectious PrPRes through all 20 crows
gavaged with infected material. We conclude that 83–100% of
crows from the population we sampled can excrete infectious
RML PrPRes in feces under conditions similar to those in our
study.
The MB+ mice developed clinical scrapie 15 d earlier than CF+
mice indicating inoculated dose of PrPRes infectivity was likely
lower for CF+ mice. We inoculated MB+ and MB2 mice to
demonstrate that brain source materials were infectious or not
infectious, respectively, not to serve as standards for titer
assessment. However, comparison with unpublished titration
results from intraperitoneal inoculation of RML mouse scrapie
into C57BL10 mice (Ann Ward and Sue Priola, Rocky Mountain
Laboratories, personal communication) suggest MB+ mice re-
ceived approximately 10-times more infectivity than CF+ mice.
Dilutions of brain and fecal material with SPBS (see Methods)
indicate that the amount of infectivity inoculated into MB+ mice
would have been about double that of CF+ mice, assuming no
influence on concentration of infectivity due to passage or
centrifuge processing. It is reasonable to expect some loss of
infectivity after removing solids from diluted crow feces by
centrifugation. It is also possible that some degradation or
absorption of infectivity occurred during passage through crow
alimentary tracts.
Our study clearly shows that RML PrPRes can persist after
passage through the crow alimentary tract. As there is variability in
resistance of different strains of PrPRes to degradation [32–36], we
cannot definitively state that passage of strains of concern would
occur. However, RML PrPRes has been shown more sensitive to
degradation than TSE field isolates after 4 h exposure to
enzymatic digestion [36]. Therefore, results of our study likely
understate potential for prion passage through the alimentary
canal of crows. Further experimental trials involving TSE prions
obtained from ovine, bovine, and cervine carcasses would be
required to definitively evaluate passage of natural TSEs through
digestive systems of scavengers and predators. Other additional
research topics could include in-vitro evaluation of PrPRes
degradation in crow digestive fluids; effects of solid, semisolid,
and liquid delivery of infective materials on passage rate and
residual infectivity in feces; postexcretion continued enzymatic and
bacterial degradation of infectivity in feces; infectivity of feces
excreted .4 h postgavage; susceptibility of crows to TSE disease
and potential for postinfection shedding of PrPRes in feces.
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Figure 1. Survival functions for treatment groups of mice.
Twenty-five crows were fed infected (PrPRes) or normal (control) mouse
brain homogenate. Five mice/crow were subsequently inoculated with
crow fecal extract from PrPRes (CF+) or control (CF2) crows. Additional
control mice were inoculated with mouse-brain homogenate with or
without PrPRes (MB+ and MB2, respectively). Sample sizes reflect early
deaths of 16 mice #3 d postinoculation (dpi). Mean and interval
estimates of survival time for MB+ and CF+ groups showed these
groups were significantly different, indicating different dose levels of
PrPRes in crow fecal extracts compared to mouse brain homogenate.
Time to death was significantly longer for CF2 than for CF+ mice
(x21 = 71.0, p,0.0001). Because all mice exposed to CF+ extracts died of
transmissible spongiform encephalopathy (given survival .3 dpi), all 20
crows gavaged with PrPRes-infected mouse brain homogenate passed
infectious doses of PrPRes to mice via fecal extracts.
doi:10.1371/journal.pone.0045774.g001
Table 2. Numbers of mice by treatment group that suffered
early inoculation-related death, exhibited clinical symptoms of
prion disease, and tested positive for scrapie prion (PrPRes) by
ELISAA.
Treatment
groupB Early deathC Clinical diseaseD PrPRes detected
CF+ 16 (100) 84 (84) 84 (84)
CF2 2 (25) 0 (23) 1 (23)
MB+ 0 (10) 10 (10) 9 (9)
MB2 0 (5) 0 (5) 0 (4)
ANumbers in parentheses indicate sample size.
BMice intraperitoneally inoculated with gamma-irradiated crow fecal (CF)
extract from crows gavaged with PrPRes (+) or control (2) mouse brain
homogenate; additional control mice were inoculated with mouse-brain
homogenate with (MB+) or without (MB2) PrPRes.
CMice that died #3 d postinoculation, presumably from fecal uric acid toxicity.
These mice were removed from the data set.
DMice that achieved a minimum threshold score, based on multiple symptoms
such as kyphosis, ataxia, stiff tail, lack of grooming, emaciation, and lethargy,
demonstrating strong clinical evidence of prion disease.
doi:10.1371/journal.pone.0045774.t002
Infectious Prion and Crow Digestive System
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